MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 21.12.2024
Genetron Holdings Limited Finanzkreislauf 2011-2026 | GTH
Finanzkreislauf Jährlich Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 142 | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 142 | 142 | 142 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
275 | $ 2.91 | 2.83 % | $ 94.4 K |  USA |
 |
Agilent Technologies
A
|
111 | $ 120.18 | 0.96 % | $ 36.5 B | USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 22.99 | -2.36 % | $ 241 M |  China |
 |
Castle Biosciences
CSTL
|
45.9 | $ 28.2 | 2.29 % | $ 783 M | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 14.09 | 2.18 % | $ 426 M | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 178.99 | 1.88 % | $ 8.87 B | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
IDEXX Laboratories
IDXX
|
103 | $ 643.83 | 1.3 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
142 | $ 130.32 | 0.59 % | $ 20.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 281.82 | -0.44 % | $ 23.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 77.77 | -1.36 % | $ 5.25 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
41.7 | $ 15.54 | 0.26 % | $ 2.02 B | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 302.74 | -1.06 % | $ 26.8 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
49.3 | $ 5.41 | 2.27 % | $ 501 M | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 9.28 | -2.73 % | $ 1.19 B | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.13 | 0.9 % | $ 1.44 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 208.42 | 0.03 % | $ 23.1 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 13.25 | -1.05 % | $ 325 M | USA |
 |
Danaher Corporation
DHR
|
77.5 | $ 204.05 | 0.02 % | $ 145 B | USA |
 |
Organovo Holdings
ONVO
|
-82.8 K | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | $ 103.38 | - | $ 19.5 B | USA |
 |
Bioventus
BVS
|
208 | $ 8.59 | -1.77 % | $ 538 M | USA |
 |
OPKO Health
OPK
|
242 | $ 1.2 | 0.42 % | $ 833 M | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 9.52 | -7.57 % | $ 270 M | Israel |
 |
DexCom
DXCM
|
134 | $ 72.81 | -0.37 % | $ 28.4 B | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.61 | 5.59 % | $ 483 M | USA |
 |
Psychemedics Corporation
PMD
|
45.3 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
62 | $ 109.61 | 0.84 % | $ 9.04 B |  Irlanda |
 |
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
-3.19 | $ 26.37 | 5.57 % | $ 34.2 M | USA |
 |
Personalis
PSNL
|
-11.5 | $ 8.92 | 2.88 % | $ 529 M | USA |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |  Britain |
 |
CareDx, Inc
CDNA
|
51.5 | $ 19.22 | 2.21 % | $ 1.02 B | USA |